Tissue-mediated control of immunopathology in coeliac disease (original) (raw)

• Green, P. H. & Cellier, C. Celiac disease. N. Engl. J. Med. 357, 1731–1743 (2007).
  Article CAS PubMed Google Scholar
• Janeway, C. A. Jr. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol. Today 13, 11–16 (1992).
  Article CAS PubMed Google Scholar
• Matzinger, P. Friendly and dangerous signals: is the tissue in control? Nature Immunol. 8, 11–13 (2007).
  Article CAS Google Scholar
• Kalinski, P., Hilkens, C. M., Wierenga, E. A. & Kapsenberg, M. L. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol. Today 20, 561–567 (1999).
  Article CAS PubMed Google Scholar
• Mora, J. R. et al. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 424, 88–93 (2003).
  Article CAS PubMed Google Scholar
• Coombes, J. L. et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β and retinoic acid-dependent mechanism. J. Exp. Med. 204, 1757–1764 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Mucida, D. et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317, 256–260 (2007).
  Article CAS PubMed Google Scholar
• Meresse, B. & Jabri, B. NKG2 Receptor-Mediated Regulation Of Effector CTL Functions In The Human Tissue Microenvironment (eds Vivier, E. & Colonna, M.) (Springer, 2006).
  Google Scholar
• Ruprecht, C. R. et al. Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia. J. Exp. Med. 201, 1793–1803 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Benahmed, M. et al. IL-15 renders conventional lymphocytes resistant to suppressive functions of regulatory T cells through activation of the phosphatidylinositol 3-kinase pathway. J. Immunol. 182, 6763–6770 (2009).
  Article CAS Google Scholar
• Sollid, L. M. et al. Evidence for a primary association of celiac disease to a particular HLA-DQ α/β heterodimer. J. Exp. Med. 169, 345–350 (1989).
  Article CAS PubMed Google Scholar
• Spurkland, A., Sollid, L. M., Polanco, I., Vartdal, F. & Thorsby, E. HLA-DR and -DQ genotypes of celiac disease patients serologically typed to be non-DR3 or non-DR5/7. Hum. Immunol. 35, 188–192 (1992).
  Article CAS PubMed Google Scholar
• Nistico, L. et al. Concordance, disease progression, and heritability of coeliac disease in Italian twins. Gut 55, 803–808 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• van Heel, D. A. et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nature Genet. 39, 827–829 (2007). The first genome wide association study of coeliac disease.
  Article CAS PubMed Google Scholar
• Hunt, K. A. et al. Newly identified genetic risk variants for celiac disease related to the immune response. Nature Genet. 40, 395–402 (2008).
  Article CAS PubMed Google Scholar
• Leonard, W. J. & Spolski, R. Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nature Rev. Immunol. 5, 688–698 (2005).
  Article CAS Google Scholar
• Salvati, V. M. et al. Interleukin 18 and associated markers of T helper cell type 1 activity in coeliac disease. Gut 50, 186–190 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Nilsen, E. M. et al. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 115, 551–563 (1998).
  Article CAS PubMed Google Scholar
• Smyth, D. J. et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N. Engl. J. Med. 359, 2767–2777 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Martinon, F. & Tschopp, J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 117, 561–574 (2004).
  Article CAS PubMed Google Scholar
• Wildin, R. S. et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nature Genet. 27, 18–20 (2001).
  Article CAS PubMed Google Scholar
• Shan, L. et al. Structural basis for gluten intolerance in celiac sprue. Science 297, 2275–2279 (2002). This paper establishes a relationship between the inability of intestinal proteases to break down gluten and the generation of an immunodominant gluten peptide for HLA-DQ2-positive patients. It also introduces bacterial prolyl endopeptidase as a potential supplement therapy in coeliac disease.
  Article CAS PubMed Google Scholar
• Arentz-Hansen, H. et al. The intestinal T cell response to α-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J. Exp. Med. 191, 603–612 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Moustakas, A. K. et al. Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes. Int. Immunol. 12, 1157–1166 (2000).
  Article CAS PubMed Google Scholar
• Molberg, Ø. et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nature Med. 4, 713–717 (1998); erratum 4, 974 (1998). The first paper to show that TG2 can post-translationally modify gluten peptides by deamidation and that T cells of the coeliac lesion preferentially recognize deamidated gluten peptides.
  Article CAS PubMed Google Scholar
• van de Wal, Y. et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J. Immunol. 161, 1585–1588 (1998).
  CAS PubMed Google Scholar
• Mazzarella, G. et al. Gliadin activates HLA class I-restricted CD8+ T cells in celiac disease intestinal mucosa and induces the enterocyte apoptosis. Gastroenterology 134, 1017–1027 (2008).
  Article CAS PubMed Google Scholar
• Troncone, R. et al. In siblings of celiac children, rectal gluten challenge reveals gluten sensitization not restricted to celiac HLA. Gastroenterology 111, 318–324 (1996).
  Article CAS PubMed Google Scholar
• Maiuri, L. et al. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 362, 30–37 (2003). This paper reports the ability of the 31–43 α-gliadin peptide, which is not recognized by T cells, to mediate innate immune effects in the coeliac mucosa.
  Article CAS PubMed Google Scholar
• Hüe, S. et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 21, 367–377 (2004). The first paper to show that gluten can induce expression of MICs by IECs.
  Article PubMed Google Scholar
• Barone, M. V. et al. Growth factor-like activity of gliadin, an alimentary protein: implications for coeliac disease. Gut 56, 480–488 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Terrazzano, G. et al. Gliadin regulates the NK-dendritic cell cross-talk by HLA-E surface stabilization. J. Immunol. 179, 372–381 (2007).
  Article CAS PubMed Google Scholar
• Cinova, J. et al. Gliadin peptides activate blood monocytes from patients with celiac disease. J. Clin. Immunol. 27, 201–209 (2007).
  Article CAS PubMed Google Scholar
• Nikulina, M., Habich, C., Flohe, S. B., Scott, F. W. & Kolb, H. Wheat gluten causes dendritic cell maturation and chemokine secretion. J. Immunol. 173, 1925–1933 (2004).
  Article CAS PubMed Google Scholar
• Junker, Y., Leffler, D. A., Wieser, H. & Schuppan, D. Gliadin activates monocytes, macrophages and dendritic cells in vitro and in vivo via Toll like receptor 4. Gastroenterology 136, A468 (2009).
  Article Google Scholar
• Lammers, K. M. et al. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology 135, 194–204. e3 (2008).
  Article CAS PubMed Google Scholar
• Doyle, H. A. & Mamula, M. J. Post-translational protein modifications in antigen recognition and autoimmunity. Trends Immunol. 22, 443–449 (2001).
  Article CAS PubMed Google Scholar
• Siegel, M. et al. Extracellular transglutaminase 2 is catalytically inactive, but is transiently activated upon tissue injury. PLoS ONE 3, e1861 (2008). This paper shows for the first time that TG2 is not constitutively active in the intestine and can be activated on TLR3-induced tissue injury.
  Article PubMed PubMed Central CAS Google Scholar
• Hovhannisyan, Z. et al. The role of HLA-DQ8 β57 polymorphism in the anti-gluten T-cell response in coeliac disease. Nature 456, 534–538 (2008). This paper shows how lack of a negative charge at position β57 of an MHC class II molecule affects the TCR repertoire and amplifies the T cell response to gluten.
  Article CAS PubMed PubMed Central Google Scholar
• Vader, W. et al. The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. Gastroenterology 122, 1729–1737 (2002).
  Article CAS PubMed Google Scholar
• Vader, W. et al. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc. Natl Acad. Sci. USA 100, 12390–12395 (2003). This paper introduces the concept that there are thresholds for activation of gluten-specific T cells. According to this model, HLA-DQ expression and the available number of T cell-stimulatory gluten peptides are crucial limiting factors for coeliac disease development.
  Article CAS PubMed PubMed Central Google Scholar
• Ploski, R., Ek, J., Thorsby, E. & Sollid, L. M. On the HLA-DQ(α1*0501, β1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201. Tissue Antigens 41, 173–177 (1993).
  Article CAS PubMed Google Scholar
• Karell, K. et al. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the european genetics cluster on celiac disease. Hum. Immunol. 64, 469–477 (2003).
  Article CAS PubMed Google Scholar
• Tollefsen, S. et al. HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease. J. Clin. Invest. 116, 2226–2236 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Fallang, L. E. et al. Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation. Nature Immunol. 10, 1096–1101 (2009). This paper shows that HLA-DQ2.5 is better at presenting gluten peptides to T cells over a prolonged period than HLA-DQ2.2. The differential risk for coeliac disease of these two HLA molecules is likely to be related to this phenomenon.
  Article CAS Google Scholar
• Todd, J. A., Bell, J. I. & McDevitt, H. O. HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329, 599–604 (1987).
  Article CAS PubMed Google Scholar
• Lee, K. H., Wucherpfennig, K. W. & Wiley, D. C. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nature Immunol. 2, 501–507 (2001).
  Article CAS Google Scholar
• Henderson, K. N. et al. A structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac disease. Immunity 27, 23–34 (2007).
  Article CAS PubMed Google Scholar
• Baker, F. J., Lee, M., Chien, Y. H. & Davis, M. M. Restricted islet-cell reactive T cell repertoire of early pancreatic islet infiltrates in NOD mice. Proc. Natl Acad. Sci. USA 99, 9374–9379 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Kim, C. Y., Quarsten, H., Bergseng, E., Khosla, C. & Sollid, L. M. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc. Natl Acad. Sci. USA 101, 4175–4179 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Qiao, S. W. et al. Refining the rules of gliadin T cell epitope binding to the disease-associated DQ2 molecule in celiac disease: importance of proline spacing and glutamine deamidation. J. Immunol. 175, 254–261 (2005).
  Article CAS PubMed Google Scholar
• Price, P. et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol. Rev. 167, 257–274 (1999).
  Article CAS PubMed Google Scholar
• van de Wal, Y. et al. Unique peptide binding characteristics of the disease-associated DQ(α1*0501, β1*0201) vs the non-disease-associated DQ(α1*0201, β1*0202) molecule. Immunogenetics 46, 484–492 (1997).
  Article CAS PubMed Google Scholar
• Henrickson, S. E. et al. T cell sensing of antigen dose governs interactive behavior with dendritic cells and sets a threshold for T cell activation. Nature Immunol. 9, 282–291 (2008).
  Article CAS Google Scholar
• Tsuji, M. et al. Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer's patches. Science 323, 1488–1492 (2009).
  Article CAS PubMed Google Scholar
• Chen, Y. et al. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376, 177–180 (1995).
  Article CAS PubMed Google Scholar
• Mora, J. R. & von Andrian, U. H. Retinoic acid: an educational “vitamin elixir” for gut-seeking T cells. Immunity 21, 458–460 (2004).
  Article CAS PubMed Google Scholar
• Iliev, I. D., Matteoli, G. & Rescigno, M. The yin and yang of intestinal epithelial cells in controlling dendritic cell function. J. Exp. Med. 204, 2253–2257 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Faria, A. M. & Weiner, H. L. Oral tolerance. Immunol. Rev. 206, 232–259 (2005).
  Article CAS PubMed Google Scholar
• Husby, S., Mestecky, J., Moldoveanu, Z., Holland, S. & Elson, C. O. Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding. J. Immunol. 152, 4663–4670 (1994).
  CAS PubMed Google Scholar
• Molberg, Ø. et al. Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls. Scand. J. Immunol. 46, 103–109 (1997).
  Article CAS PubMed Google Scholar
• Jabri, B. et al. Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease. Gastroenterology 118, 867–879 (2000).
  Article CAS PubMed Google Scholar
• Mention, J. J. et al. Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 125, 730–745 (2003).
  Article CAS PubMed Google Scholar
• Maiuri, L. et al. Interleukin 15 mediates epithelial changes in celiac disease. Gastroenterology 119, 996–1006 (2000).
  Article CAS PubMed Google Scholar
• Waldmann, T. A. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nature Rev. Immunol. 6, 595–601 (2006).
  Article CAS Google Scholar
• Blanco, P., Palucka, A. K., Pascual, V. & Banchereau, J. Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine Growth Factor Rev. 19, 41–52 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Monteleone, G. et al. Role of interferon α in promoting T helper cell type 1 responses in the small intestine in coeliac disease. Gut 48, 425–429 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Di Sabatino, A. et al. Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease. Gastroenterology 133, 1175–1187 (2007).
  Article CAS PubMed Google Scholar
• Ráki, M. et al. A unique dendritic cell subset accumulates in the celiac lesion and efficiently activates gluten-reactive T cells. Gastroenterology 131, 428–438 (2006).
  Article PubMed CAS Google Scholar
• Cammarota, G., Cuoco, L., Cianci, R., Pandolfi, F. & Gasbarrini, G. Onset of coeliac disease during treatment with interferon for chronic hepatitis C. Lancet 356, 1494–1495 (2000).
  Article CAS PubMed Google Scholar
• Troncone, R. & Auricchio, S. Rotavirus and celiac disease: clues to the pathogenesis and perspectives on prevention. J. Pediatr. Gastroenterol. Nutr. 44, 527–528 (2007).
  Article PubMed Google Scholar
• Benahmed, M. et al. Inhibition of TGF-β signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease. Gastroenterology 132, 994–1008 (2007).
  Article CAS PubMed Google Scholar
• Fina, D. et al. Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease. Gut 57, 887–892 (2008).
  Article CAS PubMed Google Scholar
• Peluso, I. et al. IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes. J. Immunol. 178, 732–739 (2007).
  Article CAS PubMed Google Scholar
• Perera, L. et al. Expression of nonclassical class I molecules by intestinal epithelial cells. Inflamm. Bowel Dis. 13, 298–307 (2007).
  Article PubMed Google Scholar
• Kasaian, M. T. et al. IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity 16, 559–569 (2002).
  Article CAS PubMed Google Scholar
• Sollid, L. M., Molberg, Ø., McAdam, S. & Lundin, K. E. Autoantibodies in coeliac disease: tissue transglutaminase — guilt by association? Gut 41, 851–852 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Matysiak-Budnik, T. et al. Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. J. Exp. Med. 205, 143–154 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Nimmerjahn, F. & Ravetch, J. V. Fcγ receptors as regulators of immune responses. Nature Rev. Immunol. 8, 34–47 (2008).
  Article CAS Google Scholar
• Patey-Mariaud de Serre, N. et al. Chronic intestinal graft-versus-host disease: clinical, histological and immunohistochemical analysis of 17 children. Bone Marrow Transplant 29, 223–230 (2002).
  Article CAS PubMed Google Scholar
• Cuenod, B. et al. Classification of intractable diarrhea in infancy using clinical and immunohistological criteria. Gastroenterology 99, 1037–1043 (1990).
  Article CAS PubMed Google Scholar
• Marsh, M. N. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 102, 330–354 (1992).
  Article CAS PubMed Google Scholar
• Kutlu, T. et al. Numbers of T cell receptor (TCR) αβ+ but not of TcR γδ+ intraepithelial lymphocytes correlate with the grade of villous atrophy in coeliac patients on a long term normal diet. Gut 34, 208–214 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Black, K. E., Murray, J. A. & David, C. S. HLA-DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice. J. Immunol. 169, 5595–5600 (2002).
  Article CAS PubMed Google Scholar
• de Kauwe, A. L. et al. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells. J. Immunol. 182, 7440–7450 (2009).
  Article CAS PubMed Google Scholar
• Yokoyama, S. et al. Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytes. Proc. Natl Acad. Sci. USA 106, 15849–15854 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Zhou, R., Wei, H., Sun, R., Zhang, J. & Tian, Z. NKG2D recognition mediates Toll-like receptor 3 signaling-induced breakdown of epithelial homeostasis in the small intestines of mice. Proc. Natl Acad. Sci. USA 104, 7512–7515 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Louka, A. S. & Sollid, L. M. HLA in coeliac disease: unravelling the complex genetics of a complex disorder. Tissue Antigens 61, 105–117 (2003).
  Article CAS PubMed Google Scholar
• Roberts, A. I. et al. NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment. J. Immunol. 167, 5527–5530 (2001).
  Article CAS PubMed Google Scholar
• Meresse, B. et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21, 357–366 (2004). The first paper to provide a molecular basis for IL-15-induced killer activity in vivo and antigen-nonspecific killing of IECs in coeliac disease and the first to report, together with reference 30, on the role of NKG2D in coeliac disease pathogenesis.
  Article CAS PubMed Google Scholar
• Jabri, B. et al. TCR specificity dictates CD94/NKG2A expression by human CTL. Immunity 17, 487–499 (2002).
  Article CAS PubMed Google Scholar
• Meresse, B. et al. Reprogramming of CTLs into natural killer-like cells in celiac disease. J. Exp. Med. 203, 1343–1355 (2006). This paper shows genetic reprogramming of CTLs into NK cell-like cells and HLA-E induction in IECs in coeliac disease. It also provides a molecular basis for cytokine production and expansion of intraepithelial lymphocytes that do not recognize gluten peptides.
  Article CAS PubMed PubMed Central Google Scholar
• Tang, F. et al. Cytosolic PLA2 is required for CTL-mediated immunopathology of celiac disease via NKG2D and IL-15. J. Exp. Med. 206, 707–719 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Werz, O. 5-lipoxygenase: cellular biology and molecular pharmacology. Curr. Drug Targets. Inflamm. Allergy 1, 23–44 (2002).
  Article CAS PubMed Google Scholar
• Halstensen, T. S., Scott, H. & Brandtzaeg, P. Intraepithelial T cells of the TcRγ/δ+ CD8− and Vδ1/Jδ1+ phenotypes are increased in coeliac disease. Scand. J. Immunol. 30, 665–672 (1989).
  Article CAS PubMed Google Scholar
• Wu, J., Groh, V. & Spies, T. T cell antigen receptor engagement and specificity in the recognition of stress-inducible MHC class I-related chains by human epithelial γδ T cells. J. Immunol. 169, 1236–1240 (2002).
  Article CAS PubMed Google Scholar
• Spada, F. M. et al. Self-recognition of CD1 by γ/δ T cells: implications for innate immunity. J. Exp. Med. 191, 937–948 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Bhagat, G. et al. Small intestinal CD8+TCRγδ+NKG2A+ intraepithelial lymphocytes have attributes of regulatory cells in patients with celiac disease. J. Clin. Invest. 118, 281–293 (2008).
  Article CAS PubMed Google Scholar
• Maki, M., Holm, K., Collin, P. & Savilahti, E. Increase in γ/δ T cell receptor bearing lymphocytes in normal small bowel mucosa in latent coeliac disease. Gut 32, 1412–1414 (1991).
  Article CAS PubMed PubMed Central Google Scholar
• Rosen, D. B. et al. A Structural basis for the association of DAP12 with mouse, but not human, NKG2D. J. Immunol. 173, 2470–2478 (2004).
  Article CAS PubMed Google Scholar
• Daum, S., Cellier, C. & Mulder, C. J. Refractory coeliac disease. Best Pract. Res. Clin. Gastroenterol. 19, 413–424 (2005).
  Article PubMed Google Scholar
• Cellier, C. et al. Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology 114, 471–481 (1998). This paper identifies for the first time the phenotypic changes — that is, the loss of surface expression of the TCR — in intraepithelial lymphocytes of patients with refractory sprue.
  Article CAS PubMed Google Scholar
• Fehniger, T. A. et al. Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells. J. Exp. Med. 193, 219–231 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Groh, V., Bruhl, A., El-Gabalawy, H., Nelson, J. L. & Spies, T. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc. Natl Acad. Sci. USA 100, 9452–9457 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Ogasawara, K. et al. NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity 20, 757–767 (2004).
  Article CAS PubMed Google Scholar
• Fabris, P. et al. Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis. Lancet 340, 548 (1992).
  Article CAS PubMed Google Scholar
• Marazuela, M. et al. Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-α therapy. Clin. Endocrinol. 44, 635–642 (1996).
  Article CAS Google Scholar
• Lundin, K. E. et al. Gliadin-specific, HLA-DQ(α1*0501, β1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J. Exp. Med. 178, 187–196 (1993).
  Article CAS PubMed Google Scholar
• Lundin, K. E., Scott, H., Fausa, O., Thorsby, E. & Sollid, L. M. T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8. Hum. Immunol. 41, 285–291 (1994).
  Article CAS PubMed Google Scholar
• Zhernakova, A., van Diemen, C. C. & Wijmenga, C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nature Rev. Genet. 10, 43–55 (2009).
  Article CAS PubMed Google Scholar
• Dieterich, W. et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nature Med. 3, 797–801 (1997). This paper identifies TG2 as the dominant antigen recognized by autoantibodes of patients with coeliac disease.
  Article CAS PubMed Google Scholar
• Fritzler, M. & Wiik, A. Autoantibody Assays, Testing and Standardization (eds Rose, I. & Mackay, I.) (Elsevier Academic, Sydney, 2006).
  Book Google Scholar
• Schellekens, G. A., de Jong, B. A., van den Hoogen, F. H., van de Putte, L. B. & van Venrooij, W. J. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J. Clin. Invest. 101, 273–281 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Ruckert, R. et al. Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis? J. Immunol. 165, 2240–2250 (2000).
  Article CAS PubMed Google Scholar
• Lorand, L. & Graham, R. M. Transglutaminases: crosslinking enzymes with pleiotropic functions. Nature Rev. Mol. Cell Biol. 4, 140–156 (2003).
  Article CAS Google Scholar
• Molberg, Ø. et al. T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase. Eur. J. Immunol. 31, 1317–1323 (2001).
  Article CAS PubMed Google Scholar
• Vader, L. W. et al. Specificity of tissue transglutaminase explains cereal toxicity in celiac disease. J. Exp. Med. 195, 643–649 (2002). This paper characterizes the enzyme specificity of TG2 and shows that the preferred substrate sequences are frequently found in proteins of wheat, rye and barley.
  Article CAS PubMed PubMed Central Google Scholar
• Dørum, S., Qiao, S. W., Sollid, L. M. & Fleckenstein, B. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease. J. Proteome Res. 8, 1748–1755 (2009).
  Article PubMed CAS Google Scholar
• Djilali-Saiah, I. et al. CTLA-4 gene polymorphism is associated with predisposition to coeliac disease. Gut 43, 187–189 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Trynka, G. et al. Coeliac disease associated risk variants in TNFAIP3 and REL implicate altered NF-κB signalling. Gut 58, 1078–1083 (2009).
  Article CAS PubMed Google Scholar